GLP-2 research guide
A factual reference for laboratories working with GLP-2: what the material is, how it is handled and stored, how to read its certificate of analysis, and how to order it in Canada. It is written for in-vitro research and makes no claims about effects in people or animals.
What is GLP-2?
GLP-2 is the catalogue name Synergy Research uses for a synthetic 39-residue peptide that binds two receptors in vitro: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It is therefore described as a dual receptor agonist. It is not the natural intestinal hormone glucagon-like peptide-2, which is a different molecule.
The chain is built on a GIP-like backbone. Aminoisobutyric acid replaces the natural residues at positions 2 and 13, which protects the peptide from cleavage by dipeptidyl peptidase-4, and the C-terminus is amidated. A C20 fatty diacid is attached to the lysine at position 20 through a linker made of a gamma-glutamate and two short polyethylene-glycol units.
The product is supplied as a lyophilised solid in a sealed glass vial, produced by solid-phase synthesis, acylation and reversed-phase purification. The related triple agonist is sold under the catalogue name GLP-3 and has its own guide.
Specification summary
Values are taken from the product page and the public PubChem record. Each lot is confirmed against them by the independent testing reported on the certificate of analysis.
Research context
Dual GIP/GLP-1 receptor agonists of this type are studied in receptor-binding and cAMP reporter assays on cells expressing each receptor individually, where their affinity and potency are compared with native GIP and GLP-1. Their acylated structure is also examined in albumin-binding studies by surface plasmon resonance and in analytical work on the characterisation of lipidated peptides by liquid chromatography and mass spectrometry.
A pharmaceutical dual agonist with this structure is an approved prescription medicine; the research-grade material sold here is not that product and is not approved for any use. This page does not describe any result of its study.
Synergy Research does not evaluate, summarise or endorse the findings of any study. The material is supplied so that laboratories can design and run their own in-vitro experiments.
Storage and handling for laboratory use
Unopened vials of GLP-2 should be stored sealed, in a cool, dry place away from light. Refrigeration at 2 to 8 °C is used for longer storage, and freezing at -20 °C is common practice for lyophilised material held for many months. The lyophilised solid is far more stable than any solution, so vials should remain unopened until they are needed.
The fatty diacid makes the lyophilised solid more sensitive to moisture and to heat than an unmodified peptide. Allow the vial to reach room temperature before opening and keep it refrigerated between uses.
Allow a cold vial to reach room temperature before removing the cap or piercing the stopper, so that moisture from the air does not condense on the solid. Record the lot number from the label in your laboratory notebook; it is the link between the vial and its certificate.
Reconstitution in the laboratory
Lyophilised material is dissolved immediately before use in a sterile diluent appropriate to the assay. Bacteriostatic water (0.9% benzyl alcohol), sterile water for laboratory use, or a neutral buffer such as phosphate-buffered saline are common choices. The diluent is added slowly down the inside wall of the vial rather than directly onto the powder, and the vial is swirled or rolled gently until the solid dissolves.
Acylated peptides of this size dissolve slowly and tend to form a gel if the diluent is added quickly. Add sterile water down the wall of the vial, let it stand, and swirl gently over several minutes; never shake. Solutions are clear and may be slightly viscous at high concentration.
The volume of diluent determines the concentration of the resulting solution; laboratories calculate it from the stated vial content and the molar mass given above. Solutions should be labelled with compound, concentration, lot number and date, kept refrigerated and protected from light, and discarded according to your own stability data. Repeated freeze-thaw cycles should be avoided; if a solution must be stored frozen, divide it into single-use aliquots first.
How to read the Certificate of Analysis
Every lot Synergy Research sells is tested by an independent Canadian laboratory, and the resulting certificate is published on the Certificates of Analysis page. A certificate has three parts worth checking before you use a vial.
- Identity. Mass spectrometry measures the molecular mass of the material and compares it with the theoretical value. For the GLP-2 dual agonist the mass spectrometry section should report a deconvoluted mass consistent with 4813.5 g/mol, from a multiply charged ion series. The HPLC trace should show a single main peak; acylated peptides often show a small, late-eluting shoulder from the lipid tail.
- Purity. Reversed-phase HPLC with UV detection separates the main compound from related impurities. The area of the main peak as a percentage of total peak area is reported as purity. Look for the chromatogram itself, not only the number.
- Traceability. The lot number on the certificate should match the number printed on your vial, and the certificate should name the testing laboratory and the date of analysis.
If a certificate for your lot is not yet posted, email [email protected] with the lot number and it will be sent when the laboratory report is in.
Frequently asked questions
Is the catalogue GLP-2 the same as the hormone glucagon-like peptide-2?
No. The natural hormone GLP-2 is a 33-residue intestinal peptide. The product sold here under the catalogue name GLP-2 is a 39-residue lipidated dual GIP/GLP-1 receptor agonist. Check the molar mass on the COA, which should be close to 4813.5 g/mol.
Is this compound the same as tirzepatide?
It is a research-grade synthetic peptide with the same dual-agonist structure. It is not the approved pharmaceutical product, is not sold under that name, and is not approved for any use in Canada.
How does it differ from GLP-3?
GLP-3 is a triple agonist that also binds the glucagon receptor and has a different sequence and mass (4731.3 g/mol). Both are lipidated 39-residue peptides.
What size is available?
The GLP-2 dual agonist is supplied as a 5mg lyophilised vial with a published certificate of analysis.
Is it approved for human or animal use?
No. It is supplied for in-vitro laboratory research only.
Buy GLP-2 in Canada
Synergy Research supplies GLP-2 as a 5mg vial. Orders ship across Canada by Canada Post Xpresspost with tracking, and payment is accepted by Interac e-Transfer or card. Every vial is matched to a published certificate of analysis.
View GLP-2 product page →See also: how to choose a research peptide supplier in Canada and the certificate archive.
For Research Use Only. Not for human or animal consumption, and not for use in diagnostic or therapeutic procedures. Nothing on this page describes, recommends or implies any use of this material in people or animals. See our Research Use Policy.